These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 27179712)

  • 1. Clinical significance of microRNAs in chronic and acute human leukemia.
    Yeh CH; Moles R; Nicot C
    Mol Cancer; 2016 May; 15(1):37. PubMed ID: 27179712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-based therapies: Revolutionizing the treatment of acute myeloid leukemia.
    Chandraprabha Vineetha R; Anitha Geetha Raj J; Devipriya P; Sreelatha Mahitha M; Hariharan S
    Int J Lab Hematol; 2024 Feb; 46(1):33-41. PubMed ID: 38105344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs in acute myeloid leukemia.
    Liao Q; Wang B; Li X; Jiang G
    Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significance.
    Navabi A; Akbari B; Abdalsamadi M; Naseri S
    Life Sci; 2022 May; 296():120437. PubMed ID: 35231484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
    Van Roosbroeck K; Calin GA
    Semin Oncol; 2016 Apr; 43(2):209-14. PubMed ID: 27040698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of miRNA genes in acute leukemia.
    Agirre X; Martínez-Climent JÁ; Odero MD; Prósper F
    Leukemia; 2012 Mar; 26(3):395-403. PubMed ID: 22143672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
    Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA: Defining a new niche in Leukemia.
    Fernandes Q
    Blood Rev; 2017 May; 31(3):129-138. PubMed ID: 28087197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant microRNA expression and its implications in the pathogenesis of leukemias.
    Babashah S; Sadeghizadeh M; Tavirani MR; Farivar S; Soleimani M
    Cell Oncol (Dordr); 2012 Oct; 35(5):317-34. PubMed ID: 22956261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance- An emphasis on the interaction of signaling pathways.
    Doghish AS; Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Fathi D; Elsakka EGE
    Pathol Res Pract; 2023 Mar; 243():154363. PubMed ID: 36764011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
    Kaymaz BT; Günel NS; Ceyhan M; Çetintaş VB; Özel B; Yandım MK; Kıpçak S; Aktan Ç; Gökbulut AA; Baran Y; Can BK
    Tumour Biol; 2015 Sep; 36(10):7915-27. PubMed ID: 25953263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insight into the role of miRNAs in leukemia.
    Zhang H; Chen Y
    Sci China C Life Sci; 2009 Mar; 52(3):224-31. PubMed ID: 19294347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in chronic lymphocytic leukemia.
    Ward BP; Tsongalis GJ; Kaur P
    Exp Mol Pathol; 2011 Apr; 90(2):173-8. PubMed ID: 21168405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OncomiR or antioncomiR: Role of miRNAs in Acute Myeloid Leukemia.
    He C; Luo B; Jiang N; Liang Y; He Y; Zeng J; Liu J; Zheng X
    Leuk Lymphoma; 2019 Feb; 60(2):284-294. PubMed ID: 30187809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
    Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
    J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
    Wang LQ; Chim CS
    Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs and response to therapy in leukemia.
    Sharifi H; Jafari Najaf Abadi MH; Razi E; Mousavi N; Morovati H; Sarvizadeh M; Taghizadeh M
    J Cell Biochem; 2019 Sep; 120(9):14233-14246. PubMed ID: 31081139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of microRNAs in chronic lymphocytic leukemia (Review).
    Zhou XX; Wang X
    Mol Med Rep; 2013 Sep; 8(3):719-25. PubMed ID: 23900739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
    Fallah P; Amirizadeh N; Poopak B; Toogeh G; Arefian E; Kohram F; Hosseini Rad SM; Kohram M; Teimori Naghadeh H; Soleimani M
    Int J Lab Hematol; 2015 Aug; 37(4):560-8. PubMed ID: 25833191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNAs in leukemia: biology and clinical impact.
    Lammens T; Durinck K; Wallaert A; Speleman F; Van Vlierberghe P
    Curr Opin Hematol; 2017 Jul; 24(4):353-358. PubMed ID: 28441150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.